Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,100.3
39.0 (1.27%)

 

  • STI Straits Times Index
    3,100.3
    39.0 (1.27%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,533.0
    1.0 (0.06%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,208.8
    16.6 (0.07%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,582.8
    -30.2 (-0.84%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    30,240.1
    -8.8 (-0.03%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,122.5
    -22.3 (-0.36%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 961.3M
  • Value: 1,209.1M
  • Rise: 179
  • Fall: 150
  • Unch: 426

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.055-0.003
Sembcorp Marine0.081-
YZJ Shipbldg SGD1.400-0.030
CapitaLandInvest3.530+0.230
Jiutian Chemical0.079+0.001
Singtel2.510+0.010
Intl Cement0.032+0.001
GSS Energy0.074+0.002
Genting Sing0.745+0.005
CapLand IntCom T2.090+0.010

World Indices

World Indices
Name Last Change
Nasdaq 14,970.0 -77.7
HSI 24,208.8
HSCEI 8,583.8
Jakarta 6,122.5
Nikkei 225 30,240.1
SSE Comp 3,582.8
Shanghai A 3,755.1
Shanghai B 271.1
KOSPI 3,133.6

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ADVENTA ADVENTA BHD
Quotes 15 Minutes Delayed. Updated at 27 Sep 2021 16:59
Last (MYR): 1.140 Change: -0.080 High: 1.220 Remarks:
Change (%): -6.56 Low: 1.130
Open 1.220 Yesterday's Close 1.220
Buy Price 1.140 Sell Price 1.150
Buy Volume ('00) 393 Sell Volume ('00) 100
Cumulative Volume ('00) 31,526 Cumulative Value 3,658,044
Click to show Stock Prices chart

Key Statistics

EPS (MYR) a -0.07709 Trailing EPS (MYR) e -0.05141 NAV (MYR) b 0.4048
PE a - Trailing PE f - Price / NAV b 2.8162
Dividend (MYR) d - Cash In Hand (MYR) g 0.0517 Issued & Paid-up Shares c 152,786,000
Dividend Yield (%) d - Price / Cash In Hand g 22.050 Treasury Shares h -
Beta - 75 Daysi 1.980 R-Squared - 75 Days(%)i 6.02 Market Cap (M) 174.176
Beta - 500 Daysi 1.710 R-Squared - 500 Days (%)i 4.59 Enterprise Value (M) 168.185
Piotroski F Score 3 Exchange Code 7191 Par Value ( MYR ) n.a.
52 Weeks Volatility (%) 97.21 6-Month VWAP 1.906 Free Float (%) 51.1
Shariah Compliant Stocks Yes
Sector & Industry Health Technology - Medical Specialties
Index Components BM HEALTH CARE / FTSE Bursa Malaysia Fledgling Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 28 Sep 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 28 Sep 2020.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ADVENTA Bursa 174.176 - - 2.8162 -
Industry HEALTH CARE EQUIPMENT & SERVICES Bursa 6,645.555 3.374 2.671 2.4316 14.199
Medical Specialties Bursa 7,782.934 3.206 2.812 2.6532 15.181
Index BM HEALTH CARE Bursa 7,209.574 7.524 5.647 2.5007 6.565
FTSE Bursa Malaysia Fledgling Index Bursa 275.796 70.571 29.604 1.1705 0.818
Local Peer TOPGLOV Bursa 21,372.939 2.715 2.715 3.5430 24.997
Local Peer HARTA Bursa 18,898.565 6.549 3.837 2.8939 9.241
Local Peer SUPERMX Bursa 5,811.159 1.524 1.524 1.2223 -
Local Peer RGTBHD Bursa 286.143 28.571 28.574 2.7977 -
Local Peer LKL Bursa 154.622 - - 0.8052 -
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 239,899.038 37.631 27.908 6.5094 0.146
Global Peer DANAHER CORP NYSE 231,660.550 66.000 66.000 5.8666 0.221
Global Peer ABBOTT LABORATORIES NYSE 220,485.623 49.293 34.744 6.5232 1.229
Global Peer MEDTRONIC PLC NYSE 174,982.216 48.525 45.064 3.3986 1.784
Global Peer INTUITIVE SURGICAL INC NASDAQ 124,146.880 117.053 76.511 11.4553 -
Global Peer STRYKER CORP NYSE 104,319.837 65.241 50.082 7.5485 0.849
Global Peer EDWARDS LIFESCIENCES CORP NYSE 74,842.993 90.895 51.178 14.5799 -
Global Peer BECTON DICKINSON & CO NYSE 72,710.764 94.799 38.987 3.0129 1.260
Global Peer BOSTON SCIENTIFIC CORP NYSE 63,646.095 - 135.996 3.9924 -
Global Peer IDEXX LABORATORIES INC NASDAQ 57,820.985 99.387 79.441 77.3566 -
Other Global Peers ALIGN TECHNOLOGY INC (NASDAQ), DEXCOM INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ALCON AG (NYSE), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), RESMED INC (NYSE), BAXTER INTERNATIONAL INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WATERS CORP (NYSE), BIO RAD LABORATORIES INC (NYSE), STERIS PLC (NYSE), COOPER COS INC (NYSE), PERKINELMER INC (NYSE), INSULET CORPORATION (NASDAQ), HOLOGIC INC (NASDAQ), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), ABIOMED INC (NASDAQ), MASIMO CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), DENTSPLY SIRONA INC (NASDAQ), BRUKER CORPORATION (NASDAQ), QIAGEN NV (NYSE), MICROPORT (HKEx), COCHLEAR LTD (ASX), PENUMBRA INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), WEIGAO GROUP (HKEx), SHOCKWAVE MEDICAL INC (NASDAQ), ANGELALIGN (HKEx), TANDEM DIABETES CARE INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), STAAR SURGICAL CO (NASDAQ), INMODE LTD (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), QUIDEL CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), Top Glove (SGX), NEOGEN CORP (NASDAQ), LIVANOVA PLC (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), NEVRO CORP (NYSE), INARI MEDICAL INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), EBOS GROUP (ASX), CONMED CORP (NYSE), THE BEAUTY HEALTH COMPANY (NASDAQ), HAEMONETICS CORP (NYSE), CAREDX INC (NASDAQ), ATRICURE INC (NASDAQ), NUVASIVE INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), AXONICS INC (NASDAQ), CUE HEALTH INC (NASDAQ), HESKA CORP (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), GLAUKOS CORPORATION (NYSE), VENUS MEDTECH-B (HKEx), VERICEL CORP (NASDAQ), LIFETECH SCI (HKEx), CARDIOFLOW-B (HKEx), BIOLIFE SOLUTIONS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), BUTTERFLY NETWORK INC (NYSE), PEIJIA-B (HKEx), LANTHEUS HOLDINGS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), KANGJI MEDICAL (HKEx), ZYLOXTB-B (HKEx), MESA LABORATORIES INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), PULMONX CORPORATION (NASDAQ), NANOSONICS LIMITED (ASX), AK MEDICAL (HKEx), ALPHATEC HLDGS INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), ATRION CORP (NASDAQ), VIEWRAY INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), CERUS CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), INOGEN INC (NASDAQ), BRONCUS-B (HKEx), DERMTECH INC (NASDAQ), 908 DEVICES INC (NASDAQ), MODERN DENTAL (HKEx), ANGIODYNAMICS INC (NASDAQ), CRYOLIFE INC (NYSE), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CIRC (HKEx), CUTERA INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), BIOVENTUS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), PAVMED INC (NASDAQ), SI BONE INC (NASDAQ), SURMODICS INC (NASDAQ), NYXOAH SA (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SISRAM MED (HKEx), INTERCURE LTD (NASDAQ), CHUNLI MEDICAL (HKEx), PULSE BIOSCIENCES INC (NASDAQ), VAPOTHERM INC (NYSE), AXOGEN INC (NASDAQ), KDL MEDICAL (HKEx), ANTARES PHARMA INC (NASDAQ), ACOTEC-B (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), HEARTCARE-B (HKEx), AVITA MEDICAL INC (NASDAQ), MISONIX INC (NASDAQ), SOLITON INC (NASDAQ), METRICS INCOME OPPORTUNITIES TRUST (ASX), STEREOTAXIS INC (NYSE American), APYX MEDICAL CORPORATION (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), NEUROPACE INC (NASDAQ), IRADIMED CORP (NASDAQ), ZYNEX INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), BASECARE-B (HKEx), TALIS BIOMEDICAL CORP (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), CYTOSORBENTS CORP (NASDAQ), ACCURAY INCORPORATED (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), ONCOCYTE CORP (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), SIENTRA INC (NASDAQ), CVRX INC (NASDAQ), YESTAR HEALTH (HKEx), INCANNEX HEALTHCARE LTD (ASX), ICECURE MEDICAL LTD (NASDAQ), PROFOUND MED CORP (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), EARGO INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), APOLLO ENDOSURGERY INC (NASDAQ), AROA BIOSURGERY LTD (ASX), QUOTIENT LTD (NASDAQ), PW MEDTECH (HKEx), CONFORMIS INC (NASDAQ), CLARITY PHARMACEUTICALS LTD (ASX), DARIOHEALTH CORP (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ENLIVEX THERAPEUTICS LTD (NASDAQ), TELA BIO INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), INTRICOM CORP (NASDAQ), INVACARE CORP (NYSE), TITAN MEDICAL INC (NASDAQ), CORMEDIX INC (NASDAQ), NEURONETICS INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), Medtecs Intl (SGX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), UGHealthcare (SGX), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), SOMNOMED LIMITED (ASX), REPRO MEDSYSTEMS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), IRIDEX CORP (NASDAQ), FONAR CORP (NASDAQ), CYCLOPHARM LIMITED (ASX), IMPEDIMED LIMITED (ASX), KELFRED (HKEx), MICRO-X LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), ALPHA PRO TECH (NYSE American), OPTISCAN IMAGING (ASX), BIOSIG TECHNOLOGIES INC (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), CRYO-CELL INTERNATIONAL INC (NASDAQ), BIOLASE INC (NASDAQ), ELECTROMED INC (NYSE American), CHECK-CAP LTD (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), NEPHROS INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), CELSION CORPORATION (NASDAQ), VOLITIONRX LIMITED (NYSE American), SDI LTD (ASX), LENSAR INC (NASDAQ), VINCENT MED (HKEx), ZOSANO PHARMA CORP (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), ELECTROCORE INC (NASDAQ), AVINGER INC (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), IMMUCELL CORP (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), NEUROMETRIX INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), BIOMERICA INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), APPLIED UV INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), EKSO BIONICS HOLDINGS INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), DIMERIX LTD (ASX), COMPUMEDICS (ASX), NEOVASC INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), YUNNAN ENERGY (HKEx), DAXOR CORP (NYSE American), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), CARDIEX LTD (ASX), BELLEROPHON THERAPEUTICS INC (NASDAQ), RESPIRI LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), Biolidics (SGX), MOTUS GI HOLDINGS INC (NASDAQ), Yunnan Energy (SGX), INSPIREMD INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), RESONANCE HEALTH LTD (ASX), SINTX TECHNOLOGIES INC (NASDAQ), PETVIVO HLDGS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), OVENTUS MEDICAL LTD (ASX), ADHERIUM LIMITED (ASX), VIVEVE MEDICAL INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), LIFE HEALTHCARE (HKEx), NUWELLIS INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), XTANT MEDICAL HLDGS INC (NYSE American), RA MEDICAL SYSTEMS INC (NYSE American), ALLEGRA ORTHOPAEDICS LIMITED (ASX), CYANOTECH CORP (NASDAQ), METALICITY LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), OSPREY MEDICAL INC NPV DFD 23/09/21(EX-SPLIT) (ASX), USCOM LTD (ASX), TRUSCREEN GROUP LTD (ASX), HUAKANG BIOMED (HKEx), STAR EQUITY HOLDINGS INC (NASDAQ), Annica (SGX), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.180
-13.64 %
10 Days --0.210
-15.56 %
20 Days --0.500
-30.49 %
Medium Term Return 3 Months --0.170
-12.98 %
6 Months -+0.335
+41.61 %
1 Year --1.210
-51.49 %
Long Term Return 2 Years 0.070+0.685
+165.93 %
3 Years 0.070+0.753
+212.66 %
5 Years 0.070+0.514
+93.29 %
Annualised Return Annualised --
+14.09 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.760 - 3.070 Change From 1 Year Low +0.380 % Change From 1 Year Low (%) +50.00
Change From 1 Year High -1.930 % Change From 1 Year High (%) -62.87
2 Years Range 0.280 - 5.180 Change From 2 Years Low +0.860 % Change From 2 Years Low (%) +307.14
Change From 2 Years High -4.040 % Change From 2 Years High (%) -77.99
5 Years Range 0.280 - 5.180 Change From 5 Years Low +0.860 % Change From 5 Years Low (%) +307.14
Change From 5 Years High -4.040 % Change From 5 Years High (%) -77.99
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The ADVENTA group is principally involved in the manufacture and distribution of medical products and devices for the healthcare industry.

The group�s workforce is over 1100 strong and are located in 4 countries.

In June 2004, ADVENTA was listed on the Malaysian Stock Exchange, Bursa Malaysia.

The subsidiaries of ADVENTA are committed to strong, sustained growth within their disciplines. The means to this are product excellence and employee commitment to customers.

The group is continuously sourcing for talents that can add strength and contribute ideas to the organization. ADVENTA intends to create value and returns through the implementation and commercialization of its ideas and innovations.

IPO Performance

Listing Date 29 Jun 2004 Full Subscription Rate (x) -
No of Placement Shares (M) - No of Public Offer Shares (M) 67.50 Public Offer Subscription Rate (x) -
IPO Price (MYR) 0.300 First Day Close (MYR) 0.280 First Week Close (MYR) 0.300
Current vs IPO Price (%) +280.00 First Day Gain (%) -6.67 First Week Gain (%) -

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Dec 2019 Part 1(2.71 MB)
Annual Report 2018 Dec 2018 Part 1(2.47 MB)
Annual Report 2017 Oct 2017 Part 1(1.15 MB)
Annual Report 2016 Oct 2016 Part 1(1.09 MB)
Annual Report 2015 Oct 2015 Part 1(1.63 MB)
Annual Report 2014 Oct 2014 Part 1(1.32 MB)
Annual Report 2013 Oct 2013 Part 1(1.50 MB)
Annual Report 2012 Oct 2012 Part 1(1.45 MB)
Annual Report 2011 Oct 2011 Part 1(0.92 MB)
Annual Report 2010 Oct 2010 Part 1(1.72 MB)
Annual Report 2009 Oct 2009 Part 1(1.15 MB)
Annual Report 2008 Oct 2008 Part 1(2.42 MB)
Annual Report 2008 Jan 2008 Part 1(0.67 MB)
Part 2(0.04 MB)
Annual Report 2007 Jan 2007 Part 1(2.62 MB)
Annual Report 2006 Jan 2006 Part 1(0.88 MB)
Annual Report 2005 Jan 2005 Part 1(0.28 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
27 Sep 2021 1.220 1.220 1.130 1.140 3,152,600 1.1603
24 Sep 2021 1.230 1.260 1.200 1.220 3,411,500 1.2337
23 Sep 2021 1.290 1.300 1.210 1.230 2,634,100 1.2402
22 Sep 2021 1.280 1.340 1.270 1.290 3,334,000 1.3075
21 Sep 2021 1.300 1.350 1.270 1.280 3,677,100 1.3033
20 Sep 2021 1.370 1.370 1.300 1.320 2,127,400 1.3179
17 Sep 2021 1.400 1.450 1.340 1.360 6,658,600 1.3996
15 Sep 2021 1.380 1.420 1.360 1.370 5,763,800 1.3939
14 Sep 2021 1.360 1.410 1.350 1.380 3,157,400 1.3723
13 Sep 2021 1.410 1.420 1.330 1.350 2,329,600 1.3546
10 Sep 2021 1.370 1.520 1.360 1.400 20,406,900 1.4533
09 Sep 2021 1.370 1.390 1.310 1.340 3,516,300 1.3388
08 Sep 2021 1.410 1.420 1.340 1.360 2,912,700 1.3661
07 Sep 2021 1.430 1.470 1.410 1.410 3,152,000 1.4309
06 Sep 2021 1.480 1.490 1.410 1.430 2,579,800 1.4389
03 Sep 2021 1.520 1.540 1.460 1.470 3,369,600 1.4887
02 Sep 2021 1.620 1.620 1.510 1.520 6,203,300 1.5489
01 Sep 2021 1.660 1.660 1.610 1.620 3,379,700 1.6291
30 Aug 2021 1.670 1.670 1.630 1.640 4,104,800 1.6434
27 Aug 2021 1.650 1.720 1.640 1.650 10,684,500 1.6792
26 Aug 2021 1.660 1.670 1.620 1.630 2,505,300 1.6380
25 Aug 2021 1.650 1.690 1.620 1.640 6,908,500 1.6599
Summary
Current 2 Weeks
(13 Sep 2021 to 27 Sep 2021)
1.410 1.450 1.130 1.140 36,246,100 -
Previous 2 Weeks
(27 Aug 2021 to 10 Sep 2021)
1.650 1.720 1.130 1.400 60,309,600 -
4 Weeks from
(29 Jul 2021 to 26 Aug 2021)
1.840 1.860 1.130 1.630 133,923,300 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.